Veterinary Assistive Reproduction Technology Market Size is valued at USD 2.66 Bn in 2024 and is predicted to reach USD 5.48 Bn by the year 2034 at a 7.6% CAGR during the forecast period for 2025-2034.
Veterinary assistive reproduction technology (ART) refers to any method of treatment or procedure that alters the reproductive cycle, gametes, or embryos in some way. There have been multiple iterations of this technology designed for usage with pets. The demand for assisted reproductive treatments and products is increasing due to the rising existence of infertility among the population base, which is caused by various illnesses such as sexually transmitted infections, post-partum infections, infections after abortions, and medically iatrogenic infections. Furthermore, leading research and development initiatives aimed at improving assisted reproductive technology and substantial industry participants consistently investing in creating new, improved products are expected to boost the market's growth.
However, the market development is hampered by the high-cost criteria for the safety and health of the veterinary assistive reproduction technology market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high veterinary assistive reproduction technology, the relatively high cost of ART products, in comparison to traditional treatments, a barrier to their adoption in both developed and underdeveloped nations. The fact that insurance does not cover or reimburse these procedures is another barrier preventing the assisted reproductive technology business from growing. However, the government may initiate initiatives to enhance ART technology and technical progress to circumvent this problem. The COVID-19 epidemic hit the assisted reproductive technology industry hard because patients were afraid to travel for treatments and because of inherent safety issues. With the COVID-19 epidemic, businesses took a nosedive for medical centres focusing on in vitro fertilization. To maintain reproductive health standards, some groups have started to take action.
The veterinary assistive reproduction technology market is segmented based on animal type, product, distribution channel, and conception method. According to animal type, the market is segmented into bovine, swine, ovine, caprine, equine, and other animals. By product, the market is segmented into outlook normal semen and sexed semen. The distribution channel segment includes private and public. By conception method, the market is segmented into artificial insemination, IVF and embryo transfer (MOET).
The normal semen veterinary assistive reproduction technology market is expected to have a major global market share in 2022. Normal sperm is more affordable than sexed sperm, and the segment is very fertile. It captures a large portion of the market. Using frozen sperm, keeping bulls with high genetic value at sperm stations, and giving quality AI sperm doses all lead to better results.
The bovine industry makes up the bulk of veterinary assistive reproduction technology usage for several reasons, including efforts by both public and private entities to promote sustainable food production, advancements in bovine reproduction technology, increased demand for dairy and beef products, and other similar aspects, especially in countries like the US, Germany, the UK, China, and India.
The North American veterinary assistive reproduction technology market is expected to record the maximum market revenue share in the near future. It can be attributed to because of the rising prevalence of infertility and the increasing popularity of fertility treatments. The combination of technological advancements and rising disposable income in North America is expected to boost demand for fertility treatments, which is good news for the regional market. In addition, Asia Pacific is projected to grow rapidly in the global veterinary assistive reproduction technology market because of the large number of animals, increasing public understanding of assisted reproductive technologies, and encouraging governmental programs.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 2.66 Bn |
|
Revenue Forecast In 2034 |
USD 5.48 Bn |
|
Growth Rate CAGR |
CAGR of 7.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Animal Type, By Product, By Distribution Channel, By Conception Method |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Genus Plc, URUS Group LP, CRV, SEMEX, Select Sires, Inc., Swine Genetics International, National Dairy Development Board, STgenetics, VikingGenetics, Geno SA, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Assistive Reproduction Technologies Market Snapshot
Chapter 4. Global Veterinary Assistive Reproduction Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Veterinary Assistive Reproduction Technologies Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Animal Type Estimates & Trend Analysis
5.1. Animal Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
5.2.1. Bovine
5.2.2. Swine
5.2.3. Ovine
5.2.4. Caprine
5.2.5. Equine
5.2.6. Other Animals
Chapter 6. Market Segmentation 2: Product Estimates & Trend Analysis
6.1. Product & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
6.2.1. Normal Semen
6.2.2. Sexed Semen
Chapter 7. Market Segmentation 3: Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
7.2.1. Private
7.2.2. Public
Chapter 8. Market Segmentation 4: Conception Method Estimates & Trend Analysis
8.1. Conception Method & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Conception Method:
8.2.1. Artificial Insemination
8.2.2. Embryo Transfer (MOET)
8.2.3. IVF
Chapter 9. Veterinary Assistive Reproduction Technologies Market Segmentation 6: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034
9.1.2. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034
9.1.3. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034
9.1.4. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034
9.1.5. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034
9.2.2. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034
9.2.3. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034
9.2.4. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034
9.2.5. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. France
9.2.5.3. Italy
9.2.5.4. Spain
9.2.5.5. UK
9.2.5.6. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034
9.3.2. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034
9.3.3. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034
9.3.4. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034
9.3.5. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million)
9.4.2. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034
9.4.3. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034
9.4.4. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034
9.4.5. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. MEA
9.5.1. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million) 2021-2034
9.5.2. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034
9.5.3. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034
9.5.4. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034
9.5.5. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034
9.5.5.1. GCC Countries
9.5.5.2. South Africa
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Genus Plc
10.2.2. URUS Group LP
10.2.3. CRV
10.2.4. SEMEX
10.2.5. Select Sires, Inc.
10.2.6. Swine Genetics International
10.2.7. National Dairy Development Board
10.2.8. STgenetics
10.2.9. VikingGenetics
10.2.10. Geno SA
10.2.11. Other Prominent Player
Veterinary Assistive Reproduction Technology Market By Animal Type-
Veterinary Assistive Reproduction Technology Market By Product-
Veterinary Assistive Reproduction Technology Market By Distribution Channel-
Veterinary Assistive Reproduction Technology Market By Conception Method-
Veterinary Assistive Reproduction Technology Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
